CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 26 enrolled
Drug / intervention
Carboplatin +6 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02017964
NCT02017964Phase 2Completed

A Phase II Study for the Treatment of Non-metastatic Nodular Desmoplastic Medulloblastoma in Children Less Than 4 Years of Age

Children's Oncology Group·interventional·Posted Dec 23, 2013·Updated Jan 9, 2023

In Brief

A Phase 2 clinical trial evaluating Carboplatin, Cognitive Assessment, and 5 other interventions for Desmoplastic/Nodular Medulloblastoma and 3 related conditions. Completed, enrolled 26 participants across 173 sites in 4 countries.

Detailed Summary

This phase II trial studies how well combination chemotherapy works in treating younger patients with newly diagnosed, non-metastatic desmoplastic medulloblastoma. Drugs used in chemotherapy, such as vincristine sulfate, cyclophosphamide, methotrexate, etoposide, and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia, Canada, Puerto Rico, United States

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 23, 2013
Enrollment StartDec 24, 2013
Primary CompletionMar 31, 2018
Study CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 12.5 years ago

Interventions

Carboplatindrug

Given IV

Cognitive Assessmentother

Optional ancillary studies

Cyclophosphamidedrug

Given IV

Etoposidedrug

Given IV

Laboratory Biomarker Analysisother

Correlative studies

Methotrexatedrug

Given IV

Vincristine Sulfatedrug

Given IV